Back to Search
Start Over
Alkermes narcolepsy drug 'could be best-in-class,' says Mizuho
- Source :
- The Fly. April 9, 2024
- Publication Year :
- 2024
-
Abstract
- Mizuho analyst Uy Ear says Alkermes' ALKS 2680 'could be best-in-class' following this morning's data release from the Phase 1b trial in the narcolepsy type 2 cohort. The orexin 2 [...]
- Subjects :
- Narcolepsy
Business
News, opinion and commentary
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.789446085